GlassScriptPhysician profile
Mark R Harrigan
NPI 1336176585
$4,171.46
in general payments reported to CMS, 2019-2025
11 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,327 · 2020: $57.73 · 2021: $56.11 · 2022: $2,032 · 2023: $522 · 2024: $19.29 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $500 · Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $500.00 |
| Food and Beverage | $198.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $1,600.00 | 2022 | |
| Silk Road Medical, INC. | $1,076.38 | 2019 | |
| Nico Corporation | $500.00 | 2023 | |
| Medtronic USA, INC. | $250.76 | 2019 | |
| Depuy Synthes Sales INC. | $209.44 | 2022 | |
| Stryker Corporation | $194.28 | 2020-2024 | Target, Axs Vecta 71 |
| Medtronic, INC. | $175.62 | 2022-2025 | Pipeline |
| Scientia Vascular | $139.24 | 2022 | |
| Microvention, INC. | $22.03 | 2023 | Chaperon Guiding Catheter, Tubing Kit - Stroke, Eric Retrieval Device |
| Brainlab, INC. | $3.71 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,922,126.64 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Harrigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.